Literature DB >> 17043276

Treatment of elderly breast cancer patients in a community hospital setting.

David A Litvak1, Rajeev Arora.   

Abstract

HYPOTHESIS: Elderly breast cancer patients are underdiagnosed and undertreated in a community hospital setting.
DESIGN: Retrospective study of tumor registry patients.
SETTING: Community hospital. PATIENTS: A total of 354 breast cancer patients aged 70 years or older diagnosed between 1992 and 2002 were identified from the tumor registry. The data for 3 prospectively chosen age subgroups (aged 70-74, 75-79, and > or =80 years) were subsequently analyzed. MAIN OUTCOME MEASURES: Data were collected regarding the method of detection of cancer, tumor characteristics and staging, type of treatment, and patient comorbidities. Comparisons between age subgroups were made using a likelihood ratio chi2 test.
RESULTS: Forty-six percent of all patients presented with palpable breast cancer. Mammography was frequently used as an adjunct to the physical examination but was helpful in detecting occult disease in only 54% of all patients and 38% of patients older than 80 years. Although more than 70% of patients were considered stage I or II, complete pathologic staging was only performed in 64% of patients. Approximately 50% of patients were treated with breast-conservation surgery; however, adjuvant radiation therapy was omitted in 55% of these patients. Additionally, only 29% of patients with positive lymph nodes received chemotherapy, and 67% patients who were estrogen receptor-positive received adjuvant hormonal therapy.
CONCLUSIONS: Older breast cancer patients are more likely to be diagnosed and staged clinically. Mammography is underused as a screening modality. While breast-conservation surgery was performed in about half of the patients, adjuvant radiation, chemotherapy, and hormonal therapies were frequently excluded.

Entities:  

Mesh:

Year:  2006        PMID: 17043276     DOI: 10.1001/archsurg.141.10.985

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

1.  Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer.

Authors:  Terry S Field; Jaclyn L F Bosco; Marianne N Prout; Heather T Gold; Sarah Cutrona; Pamala A Pawloski; Marianne Ulcickas Yood; Virginia P Quinn; Soe Soe Thwin; Rebecca A Silliman
Journal:  J Am Coll Surg       Date:  2011-10-19       Impact factor: 6.113

2.  Predictors of mammography use in older women with disability: the patients' perspectives.

Authors:  Mabel Caban; Yong Fang Kuo; Mukaila Raji; Alai Tan; Jean Freeman
Journal:  Med Oncol       Date:  2010-09-21       Impact factor: 3.064

3.  Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.

Authors:  Mara A Schonberg; Edward R Marcantonio; Donglin Li; Rebecca A Silliman; Long Ngo; Ellen P McCarthy
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

4.  Breast cancer in elderly women (≥ 80 years): variation in standard of care?

Authors:  Amy Cyr; William E Gillanders; Rebecca L Aft; Timothy J Eberlein; Julie A Margenthaler
Journal:  J Surg Oncol       Date:  2010-11-23       Impact factor: 3.454

Review 5.  Surgery in the Older Patient with Breast Cancer.

Authors:  Julia Frebault; Carmen Bergom; Amanda L Kong
Journal:  Curr Oncol Rep       Date:  2019-06-25       Impact factor: 5.075

6.  Breast cancer treatment practices in elderly women in a community hospital.

Authors:  Hua Wang; Awinder P Singh; Serena A St Luce; Alan R Go
Journal:  Int J Breast Cancer       Date:  2011-11-17

Review 7.  Radiation therapy for the elderly-change of concepts in breast cancer?

Authors:  András Szigeti; Edit Szigeti; Aneta Grajda
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

Review 8.  Older breast cancer undertreatment: unconscious bias to undertreat-potential role for the international geriatric radiotherapy group?

Authors:  Nam P Nguyen; Ulf Karlsson; Eromosele Oboite; Julio Alvarenga; Juan Godinez; Alice Zamagni; Micaela Motta; Satya Bose; Vincent Vinh-Hung
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.